GlassScriptPhysician profile
Amy Gilliam
NPI 1073571139
$3,171.99
in general payments reported to CMS, 2019-2025
19 companies · $1,850 in 2025
The $1,850 reported for 2025 was more than what a typical Pediatric Dermatology provider received nationally (typical 2025 total: $302).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $23.42 · 2020: $97.67 · 2022: $449 · 2023: $377 · 2024: $376 · 2025: $1,850.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,487 · Education: $115.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,487.39 |
| Education | $114.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $491.72 | 2020-2025 | Dupixent |
| Arcutis Biotherapeutics, INC. | $349.22 | 2024-2025 | Zoryve |
| Incyte Corporation | $333.87 | 2022-2025 | Opzelura |
| Pfizer INC. | $330.95 | 2022-2025 | |
| Lilly USA, LLC | $282.98 | 2024-2025 | Ebglyss, Taltz, Olumiant |
| Organon LLC | $230.17 | 2025 | Vtama |
| Galderma Laboratories, L.P. | $205.34 | 2024-2025 | Nemluvio |
| Genzyme Corporation | $181.06 | 2025 | |
| Janssen Biotech, INC. | $167.84 | 2023-2025 | Tremfya |
| Pierre Fabre Pharmaceuticals, INC. | $140.00 | 2022 | |
| Leo Pharma INC. | $126.75 | 2022-2025 | Adbry |
| Abbvie INC. | $97.23 | 2022-2023 | |
| Sun Pharmaceutical Industries INC. | $62.66 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $44.21 | 2025 | |
| Verrica Pharmaceuticals INC. | $37.74 | 2024 | Ycanth |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Krystal Biotech INC | $30.36 | 2023 | Vyjuvek |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $20.92 | 2024 | Cabtreo, Arazlo, Jublia |
| Ucb, INC. | $20.67 | 2024 | Bimzelx |
| Strata Skin Sciences, INC. | $18.30 | 2024 | Xtrac |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Gilliam listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.